Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Cash Flow Reinvestment Rate
Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Cash Flow Reinvestment Rate of 3.85x as of December 2024, reinvesting CN¥471.54 Million (capex CN¥129.71 Million plus investments CN¥-341.83 Million) from operating cash flow of CN¥122.51 Million. Check how high is Nanjing Medlander Medical Technology Co.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nanjing Medlander Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. Explore Nanjing Medlander Medical Technology Co. (688273) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
Year-by-year capital reinvestment analysis for Nanjing Medlander Medical Technology Co. Ltd. A. For live market cap and broader valuation context, see 688273 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.85x | CN¥471.54 Million | CN¥122.51 Million | CN¥129.71 Million | ▲ +131.6% |
| 2023 | 1.66x | CN¥227.50 Million | CN¥136.91 Million | CN¥75.15 Million | ▲ +49.7% |
| 2022 | 1.11x | CN¥140.57 Million | CN¥126.67 Million | CN¥54.26 Million | ▲ +607.4% |
| 2021 | 0.16x | CN¥23.31 Million | CN¥148.60 Million | CN¥14.58 Million | ▼ -59.2% |
| 2020 | 0.38x | CN¥50.41 Million | CN¥131.10 Million | CN¥25.91 Million | — |